| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | VERSARTIS INC COM | 1,994,568 | 55,928,000 | 16.17% | ||
| 2 | TRANSENTERIX INC | 8,335,819 | 42,010,000 | 12.14% | ||
| 3 | ZELTIQ AESTHETICS INCORPORATED | 2,597,742 | 39,460,000 | 11.41% | ||
| 4 | CEMPRA INC | 3,293,060 | 35,330,000 | 10.21% | ||
| 5 | DURATA THERAPEUTICS INC | 2,030,175 | 34,570,000 | 9.99% | ||
| 6 | CHIMERIX INC | 1,522,943 | 33,410,000 | 9.66% | ||
| 7 | Esperion Therapeutics Inc | 2,054,594 | 32,540,000 | 9.41% | ||
| 8 | Agile Therapeutics, Inc. | 2,171,831 | 18,940,000 | 5.47% | ||
| 9 | PERNIX THERAPEUTICS HLDGS IN | 2,010,000 | 18,050,000 | 5.22% | ||
| 10 | SORRENTO THERAPEUTICS INC COM NEW | 1,763,500 | 11,900,000 | 3.44% | ||
| 11 | AMBIT BIOSCIENCES CORP | 1,650,156 | 11,400,000 | 3.30% | ||
| 12 | LOMBARD MEDICAL INC | 886,363 | 6,380,000 | 1.84% | ||
| 13 | MEI PHARMA INC | 770,000 | 4,880,000 | 1.41% | ||
| 14 | ZELTIQ AESTHETICS INCORPORATED | 43,261 | 657,000 | 0.19% | Call | |
| 15 | CEMPRA INC | 40,000 | 429,000 | 0.12% | Call | |
| 16 | PERNIX THERAPEUTICS HLDGS IN | 10,000 | 90,000 | 0.03% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0000950142-14-001866, filed 2014.09.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
